相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
Marlijn Hoeks et al.
HAEMATOLOGICA (2020)
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelody-splastic syndromes and acute myeloid leukemia
Nabih Maslah et al.
HAEMATOLOGICA (2020)
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
Hideaki Ogiwara et al.
CANCER CELL (2019)
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II
Courtney L. Jones et al.
BLOOD (2019)
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
Yilong Zou et al.
NATURE COMMUNICATIONS (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myelodysplasies (GFM)
Thomas Cluzeau et al.
BLOOD (2019)
Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)
David A. Sallman et al.
BLOOD (2019)
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
Jennifer Tsoi et al.
CANCER CELL (2018)
FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation
Michael M. Gaschler et al.
NATURE CHEMICAL BIOLOGY (2018)
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma
Heike Miess et al.
ONCOGENE (2018)
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
Qiang Zhang et al.
CELL DEATH & DISEASE (2018)
Unsolved mysteries: How does lipid peroxidation cause ferroptosis?
Huizhong Feng et al.
PLOS BIOLOGY (2018)
Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders
Jia-rui Wu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer
Pranavi Koppula et al.
CANCER COMMUNICATIONS (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Glutathione peroxidase 4: a new player in neurodegeneration?
B. R. Cardoso et al.
MOLECULAR PSYCHIATRY (2017)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
R. M. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inhibiting the system x(C)over-bar/glutathione axis selectively targets cancers with mutant-p53 accumulation
David S. Liu et al.
NATURE COMMUNICATIONS (2017)
PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
Anne Perdrix et al.
CANCERS (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein et al.
BLOOD (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy
Vladimir J. N. Bykov et al.
FRONTIERS IN ONCOLOGY (2016)
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
Nathalie Jacque et al.
BLOOD (2015)
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
David S. H. Liu et al.
GUT (2015)
The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
Yan Yu et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance
Benoit Tessoulin et al.
BLOOD (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines
Patricia Izetti et al.
INVESTIGATIONAL NEW DRUGS (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Scott J. Dixon et al.
ELIFE (2014)
PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
Manujendra N. Saha et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
Soren Lehmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
N. Takahashi et al.
CELL DEATH & DISEASE (2012)
APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells
Dina Ali et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma
Jong-Lyel Roh et al.
ORAL ONCOLOGY (2011)
MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells
Wenrui Duan et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
J. M. R. Lambert et al.
ONCOGENE (2010)
PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
Jeremy M. R. Lambert et al.
CANCER CELL (2009)
PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion
H Nahi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
VJN Bykov et al.
ONCOGENE (2005)
Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion
H Nahi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
分享论文
